| 摘要 |
<p>The present invention concerns methods and compositions for treatment of locoregional nasopharyngeal carcinoma utilizing EBV- specific T cells. In specific embodiments, locoregional solid tumors are treated with cytotoxic T lymphocytes specific for at least one EBV antigen, such as LMP2, LMPl, and/or EBNAl, for example.</p> |
| 申请人 |
BAYLOR COLLEGE OF MEDICINE |
发明人 |
HESLOP, HELEN, E.;STRAATHOF, KARIN;GOTTSCHALK, STEPHEN, M.G.;ROONEY, CLIONA, M.;LOUIS, CHRYSTAL, U.;BRENNER, MALCOLM, K. |
